Stephen Kornblau

492 total citations
5 papers, 36 citations indexed

About

Stephen Kornblau is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Stephen Kornblau has authored 5 papers receiving a total of 36 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in Stephen Kornblau's work include Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Insect Resistance and Genetics (1 paper). Stephen Kornblau is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Insect Resistance and Genetics (1 paper). Stephen Kornblau collaborates with scholars based in United States, Netherlands and Italy. Stephen Kornblau's co-authors include Cristi Gidel, Maher Albitar, Taghi Manshouri, Sherry Pierce, Jörge E. Cortes, Carlo M. Croce, Hagop M. Kantarjian, Apostolia M. Tsimberidou, Elihu H. Estey and Anthony J. Murgo and has published in prestigious journals such as Investigational New Drugs, Leukemia Research and HemaSphere.

In The Last Decade

Stephen Kornblau

4 papers receiving 36 citations

Peers

Stephen Kornblau

MB

HEMAT

GENET

ONCOL

Frédéric Millot France

Peer Wünsche Germany

Gudrun Goehring Germany

Chloé Arfeuille France

I Hassan Pakistan

Hans‐Walter Lindemann Germany

Tiebin Jiang China

I. V. Kryuchkova Russia

Roberto Ovilla Mexico

Paola Bonaccorso Italy

Frédéric Millot France

Stephen Kornblau

12 ×0.6

MB

18 ×1.1

HEMAT

8 ×0.7

GENET

7 ×0.8

GENET

5 ×0.6

ONCOL

Citations per year, relative to Stephen Kornblau Stephen Kornblau (= 1×) peers Frédéric Millot

Countries citing papers authored by Stephen Kornblau

Since Specialization

Citations

This map shows the geographic impact of Stephen Kornblau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Kornblau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Kornblau more than expected).

Fields of papers citing papers by Stephen Kornblau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Kornblau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Kornblau. The network helps show where Stephen Kornblau may publish in the future.

Co-authorship network of co-authors of Stephen Kornblau

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Kornblau. A scholar is included among the top collaborators of Stephen Kornblau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Kornblau. Stephen Kornblau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Pemmaraju, Naveen, Naval Daver, Elias Jabbour, et al.. (2019). S829 SOTATERCEPT (ACE‐011) IN SUBJECTS WITH MPN‐ASSOCIATED MYELOFIBROSIS AND ANEMIA. HemaSphere. 3(S1). 367–368. 4 indexed citations

2.

Gallardo, Miguel, Xiaorui Zhang, Huaxian Ma, et al.. (2017). 2180. Journal of Clinical and Translational Science. 1(S1). 58–58.

3.

Giles, Francis J., Hagop M. Kantarjian, Jörge E. Cortes, et al.. (2005). Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes. Leukemia Research. 29(6). 649–652. 10 indexed citations

4.

Albitar, Maher, Taghi Manshouri, Cristi Gidel, et al.. (2001). Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia. Leukemia Research. 25(10). 859–864. 11 indexed citations

5.

Giles, Francis J., Jörge E. Cortes, Guillermo Garcia-Manero, et al.. (2001). Phase I Study of Irofulven (MGI 114), an Acylfulvene Illudin Analog, in Patients with Acute Leukemia. Investigational New Drugs. 19(1). 13–20. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact